Get notified when CRIS files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsCuris doubles authorized shares to 567M, eliminates two preferred stock series
Filed May 22, 2026 · Period ending May 19, 2026 · ~1 min read
Key Changes
-
high
Shareholders approved doubling authorized common stock from 284M to 567M shares, significantly expanding the company's ability to issue new equity for financing, acquisitions, or compensation—potentially diluting existing holders.
Item 5.03: Shareholder vote verify on EDGAR → -
medium
Company eliminated Series A and Series B preferred stock designations, returning these shares to undesignated preferred stock and simplifying the capital structure while giving the board flexibility to create new preferred series.
Item 3.03: Rights modification verify on EDGAR → -
low
Two Class III directors elected to three-year terms expiring 2029: Martyn Greenacre and Kenneth Kaitin, both receiving over 98% support from voting shareholders.
Item 5.07: Director elections verify on EDGAR →
1 more material change behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (ADMT 10-K) is open in full — no account needed.
Partner
Trade CRIS commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Source-verified from EDGAR · Narrative written by AI · May 27, 2026 · How we verify